GNPX - Genprex - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-4.314M

Cash

8.217M

Avg Qtr Burn

-5.776M

Short % of Float

2.68%

Insider Ownership

1.67%

Institutional Own.

6.82%

Qtr Updated

03/31/24

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
REQORSA (quaratusugene ozeplasmid) + Tagrisso Details Lung cancer, Non-small cell lung carcinoma, Cancer	Phase 2a Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REQORSA (quaratusugene ozeplasmid) + Keytruda Details Cancer, Non-small cell lung carcinoma, Lung cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REQORSA (quaratusugene ozeplasmid) + Tecentriq Details Lung cancer, Cancer, Small cell lung cancer	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.